News & Updates
The latest news and advances from the world's most exciting life science cluster.
Just-Evotec Biologics announced a $28.6 million agreement with the Department of Defense to manufacture monoclonal antibodies for use against the COVID-19 virus. The antibody treatment
Bristol Myers Squibb gained FDA approval for its CAR-T drug liso-cel, which will be called Breyanzi. The drug will be available for patients with certain
Seattle’s Sana Biotechnology raised $588 million in its stock market debut, showcasing investors’ continued interest in the life science industry after a record-setting 2020. The
Washington’s life science sector is looking to build upon 2020’s record funding as the industry continues to provide critical research and treatments to combat the
A CBRE study measuring LinkedIn data from September 2019 to September 2020 showed that Seattle is leading the nation in net tech talent gain, up
Life Science Washington announced the addition of eight new members to its Board of Directors. New directors represent prominent universities, research institutions and funders in addition